We chat with Adam Stoten, the chief operating officer of Oxford University Innovation, about vaccines – not just for covid but also one for tuberculosis he helped develop at a spinout – as well as the importance of REF, KEF and the Knowledge Exchange Concordat, and the success of LAB282. He also exclusively reveals what is next for him personally.

“Funk Game Loop” Kevin MacLeod (incompetech.com)

Licensed under Creative Commons: By Attribution 3.0

The post Adam Stoten: Oxford University Innovation first appeared on Beyond the Breakthrough.